IFLR1000

News and features

Articles

Article type
Practice area

Showing 1 - 10 of 17

News & Analysis

India: Delhi High Court vacates ex-parte injunction on grounds of gross suppression of facts. Imposes heavy cost on the Plaintiffs

24 March 2022 by L&L Partners

In an order pronounced today, the Delhi High Court had vacated an e-parte interim injunction granted in August 2019, on account of material suppression of facts by the Plaintiffs, Kent RO Systems and its Managing Director.
News & Analysis

India: No. 1 in the world!! Proud to be a part

14 March 2022 by L&L Partners

'THE PAANI FOUNDATION' ranked the no. 1 'Earth healing project in the world'
News & Analysis

India: L&L Partners Recent Deals

21 February 2022 by L&L Partners

L&L Partners' latest deals.
News & Analysis

India: L&L Partners get major relief for NHPC Limited

03 February 2022 by L&L Partners

L&L Partners get major relief for NHPC Limited - A leading hydropower generation Public Sector Undertaking in arbitration proceedings arising over a dispute for civil and hydromechanical works of a Hydro Electric Project.

News & Analysis

India: L&L Partners represents, advises InterviewBit Technologies in Series B financing round

03 February 2022 by L&L Partners

L&L Partners has recently represented and advised InterviewBit Technologies (“Scaler Academy”), an edtech start-up that offers courses to working professionals in India and abroad to upgrade their skills, in raising $55 million in its Series B financing round.
News & Analysis

India: Recent deals

10 January 2022 by L&L Partners

Capital Markets team advised Venus Pipes & Tubes Limited and SMC Capitals Limited in the filing of the draft offer document in relation to the proposed Initial Public Offering of the equity shares of the Company.
News & Analysis

India: Carlyle Group’s generic pharma platform Viyash, invests in Appcure Labs and Appco Pharma LLC

24 November 2021 by L&L Partners

L&L Partners Law Offices advised the Carlyle Group on the acquisition of 100% stake of Appcure Labs Private Limited and the acquisition of majority stake in Appco Pharma LLC through its generic pharma platform, Viyash Life Sciences Private Limited.
News & Analysis

India: Carlyle Group’s investments in Viyash Life Sciences Private Limited, an integrated generic pharmaceuticals platform

24 November 2021 by L&L Partners

L&L Partners Law Offices advised the Carlyle Group (“Carlyle”), on setting up an integrated generic pharmaceuticals platform, known as Viyash Life Sciences Private Limited in partnership with ex-Mylan senior executive, Dr. Hari Babu Bodepudi and ex- founder of Laurus Labs, Dr. Srihari Raju Kalidindi. L&L has also advised Carlyle on all its follow-on investments into Viyash over a period of time.
News & Analysis

India: Virescent Renewable Energy Trust Bond Issuance

18 November 2021 by L&L Partners

The Firm’s Banking and Finance team advised Virescent Renewable Energy Trust (the “InvIT”) in the private placement of up to 10,000 non-convertible debt securities aggregating up to Rs. 1000,00,00,000 (Rupees one thousand crores) across three, five and seven- year tranches (the “Issue”).

News & Analysis

India: L&L Partners acts for and advises NIIF Infrastructure Finance Limited in connection with the financial assistance

22 October 2021 by L&L Partners

L&L Partners has recently acted for and advised NIIF Infrastructure Finance Limited in connection with the financial assistance aggregating up to INR 2200.00 Million to TVS Industrial & Logistics Parks Private Limited
Load more